Article Information
History
- May 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Erin Teeple1,
- Pooja Joshi2,
- Rahul Pande1,
- Yinyin Huang1,
- Akshat Karambe1,
- Martine Latta-Mahieu2,
- S. Pablo Sardi2,
- Angel Cedazo-Minguez2,
- Katherine W. Klinger1,
- Amilcar Flores-Morales2,
- Stephen L. Madden1,
- Deepak Rajpal1 and
- Dinesh Kumar1,#
- 1Translational Sciences, Sanofi, Framingham, MA 01701, USA
- 2Neurological and Rare Diseases Therapeutic Area, Sanofi, Chilly-Mazarin 91385, France
- ↵#To whom correspondence should be addressed. Tel: 1-508-270-2459; Email: dinesh.kumar3{at}sanofi.com